About Kaken

History

  • 1948
    Riken reorganized into Kagaku-Kenkyusho
    Penicillin Kaken launched
  • 1950
    Streptomycin Kaken launched
  • 1952
    Kagaku-Kenkyusho renamed Kaken Chemicals
  • 1953
    Komagome Factory opened
    Athletan (anti-trichophyton product) launched
  • 1961
    Kaken Chemicals listed on the Second Section of the Tokyo Stock Exchange
  • 1962
    Kaken Chemicals listed on the First Section of the Tokyo Stock Exchange
  • 1963
    Shizuoka Factory opened
  • 1965
    The 11th Okochi Memorial Prize received
  • 1971
    The 17th Okochi Memorial Prize received
  • 1982
    Kaken Chemicals merged with Kakenyaku-Kako to form KAKEN PHARMACEUTICAL CO., LTD.
  • 1986
    Kaken Realty & Service Co., Ltd. established
  • 1987
    Artz launched
  • 1988
    Kaken Pharma Co., Ltd. established
    Adofeed launched
  • 1989
    Ebrantil launched
  • 1992
    Procylin launched
    Mentax launched
  • 1993
    Artz Dispo launched
  • 1994
    The 40th Okochi Memorial Prize received
  • 1995
    Cytotec launched
    The 41th Okochi Memorial Prize received
  • 1996
    Mentax approved by U.S. Food and Drug Administration
  • 1998
    50th Anniversary
    Bunkyo Green Court completed
    Seprafilm launched
  • 2000
    Shiga Factory closed
  • 2001
    ISO14001 obtained in Shizuoka site
    Mirol launched
    Fiblast Spray launched
  • 2002
    Mentax launched as OTC drug in the United States
    Compliance Program instituted
  • 2004
    Mentax Spray launched
  • 2005
    GHRP KAKEN launched
    bFGF-the rights to develop, manufacture and sell on a world basis obtained
  • 2006
    Licensing Agreement for Antifungal compound “KP-103” in North America and Europe
    Fiblast Spray is licensed-out to South Korea
  • 2007
    Licensing Agreement for Dental Applications of bFGF in North America and Europe
    Berasus launched
  • 2008
    Adfeed Pap launched
  • 2009
    License Agreement for bFGF in Wound Healing Applications in Europe and North America
  • 2010
    Clexane launched
  • 2011
    Lipidil launched
  • 2014
    Clenafin launched
  • 2015
    Licensing Agreement for BBI-4000 in Japan
  • 2016
    License agreement for MediWound's NexoBrid in Japan
    Distributing Agreement for Clenafin/Jublia in South Korea